Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
AstraZeneca/Daiichi Sankyo reapply for EU approval of Dato-DXd by end of 2025?  | Binary | 3 | 1 day ago | ||
Dato-DXd receives FDA approval for lung cancer by end of 2025? | Binary | 3 | 1 day ago | ||
First company to get ADC approved for lung cancer in EU by end of 2025? | Categorical | 3 | 1 day ago | ||
New phase III trial for Dato-DXd in lung cancer announced by mid-2025? | Binary | 2 | 1 day ago | ||
Next EU regulatory action for Dato-DXd by end of 2025? | Categorical | 2 | 1 day ago | ||
Outcome of next major clinical trial for Dato-DXd by end of 2025? | Categorical | 2 | 1 day ago |